Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma.
Pei-Pei WangYueyun ChenQingqin LongQing LiJiangfang TianTing LiuYong WuZhen-Yu DingPublished in: Journal for immunotherapy of cancer (2022)
High expression of ICs was associated with poor OS of patients with ESCC. PD-L1/TIM3 and PD-L1/TIGIT were the optimal combinations for predicting OS, which might be potential targets for future ICBs therapy of ESCC.